ArticleHaematologica2020

Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma.

Elisabet E Manasanch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.